Terlipressin-induced hyponatremic seizure

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 4, 2010, Pages 501-504

  Hyun, Jong Jin ^a   Seo, Yeon Seok ^a   Lee, Kwang Gyun ^a   Keum, Bora ^a   Yim, Hyung Joon ^a   Jeen, Yoon Tae ^a   Chun, Hoon Jai ^a   Um, Soon Ho ^a   Kim, Chang Duck ^a   Ryu, Ho Sang ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Cirrhosis; Hyponatremia; Seizure; Terlipressin; Varix

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; INSULIN; PHENYTOIN; SODIUM; SODIUM CHLORIDE; TERLIPRESSIN; VASOPRESSIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANAMNESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIABETIC PATIENT; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS VARICES BLEEDING; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENERAL CONDITION IMPROVEMENT; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPONATREMIA; HYPONATREMIC SEIZURE; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LIVER HYPERTROPHY; MALE; MELENA; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTHROMBIN TIME; SEIZURE; SERUM OSMOLALITY; SODIUM BLOOD LEVEL; SPLENOMEGALY; THROMBOCYTE COUNT; VEIN LIGATION;

HUMANS; HYPONATREMIA; LYPRESSIN; MALE; MIDDLE AGED; SEIZURES; VASOCONSTRICTOR AGENTS;

EID: 77949900202     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365520903477355     Document Type: Article

References (16)

1. D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003;38:599-612.
2. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003;98:653-659
3. Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC. Portal hypertension and gastrointestinal bleeding. Semin Liver DisSemin Liver Dis 2008;28:3-25.
4. Seo YS, Kim YH, Ahn SH, Yu SK, Baik SK, Choi SK, et al. Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis. J Korean Med SciMed Sci 2008;23:635-643
5. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167-176
6. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology (Baltimore, Md) 2007;46:922-938
7. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55: 403-408
8. Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008;40:371-378
9. Holmes CL, Landry DW, Granton JT. Science review: Vasopressin and the cardiovascular system part 1-receptor physiology. Crit Care 2003;7:427-434
10. Bosch J, Lebrec D, Jenkins SA. Development of analogues: successes and failures. Scand J Gastroenterol Suppl 1998;226:3-13.
11. Dunwoodie E, Jowett S. Terlipressin causing a hyponatraemic seizure. Scand J Gastroenterol 2007;42:665.
12. Douriez E, Mollard P, Laval C, Albengres E, Laporte JP, Tillement JP. Severe hyponatremia after repeated administration of terlipressin (in French). Therapie 1993;48: 518-519
13. Martin-Llahi M, Pepin MN, Guevara M, Diaz F, Torre A, Monescillo A, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 2008;134:1352-1359
14. Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 2008;134:1360-1368
15. Salerno F, Gerbes A, Gines P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007;56:1310-1318
16. Arroyo V, Fernandez J, Gines P. Pathogenesis and treatment of hepatorenal syndrome. Semin Liver Dis 2008;28:81-95.